EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 5.95 Delayed Data As of Jun 02 |  -0.01 / -0.17%Today’s Change | 2.19 Today|||52-Week Range 11.44 | +70.00% Year-to-Date |
Latest EYPT News | Press Releases
No recent news for EyePoint Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.96 |
| Today’s open | 6.02 |
| Day’s range | 5.83 - 6.02 |
| Volume | 14,108 |
| Average volume (3 months) | 681,097 |
| Market cap | $203.1M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -34.90% |
| Earnings growth (this year) | -0.73% |
| Earnings growth (next 5 years) | +31.90% |
| Revenue growth (last year) | +12.09% |
| P/E ratio | NM |
| Price/Sales | 3.15 |
| Price/Book | 2.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AKBAAkebia Therapeutics ... | 0.00 | 0.00% |
| GNFTGenfit SA | +0.07 | +1.69% |
| ---- | ||
| CTXRCitius Pharmaceutica... | +0.08 | +6.45% |
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 2, 2023 |
| EPS forecast (this quarter) | -$0.69 |
| Annual revenue (last year) | $41.4M |
| Annual profit (last year) | -$102.3M |
| Net profit margin | -246.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
